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The inoculum size effect in the dimorphic fungus Candida albicans results from production of an extracellular
quorum-sensing molecule (QSM). This molecule prevents mycelial development in both a growth morphology
assay and a differentiation assay using three chemically distinct triggers for germ tube formation (GTF):
L-proline, N-acetylglucosamine, and serum (either pig or fetal bovine). In all cases, the presence of QSM
prevents the yeast-to-mycelium conversion, resulting in actively budding yeasts without influencing cellular
growth rates. QSM exhibits general cross-reactivity within C. albicans in that supernatants from strain A72 are
active on five other strains of C. albicans and vice versa. The QSM excreted by C. albicans is farnesol (C15H26O;
molecular weight, 222.37). QSM is extracellular, and is produced continuously during growth and over a
temperature range from 23 to 43°C, in amounts roughly proportional to the CFU/milliliter. Production is not
dependent on the type of carbon source nor nitrogen source or on the chemical nature of the growth medium.
Both commercial mixed isomer and (E,E)-farnesol exhibited QSM activity (the ability to prevent GTF) at a
level sufficient to account for all the QSM activity present in C. albicans supernatants, i.e., 50% GTF at ca. 30
to 35 mM. Nerolidol was ca. two times less active than farnesol. Neither geraniol (C10), geranylgeraniol (C20),
nor farnesyl pyrophosphate had any QSM activity.
The dimorphic fungus Candida albicans is one of the most
important fungi in medicine (26). It is a member of the normal
flora residing in the intestinal tract of humans and other ani-
mals and is thought to be acquired during passage through the
birth canal (26). C. albicans is also the model system for study-
ing the basic biology of dimorphic fungi. Because of its medical
importance, molecular tools are available with C. albicans that
are unavailable for other dimorphic fungi (3). One unresolved
problem in fungal biology is the dependence of cell morphol-
ogy on initial cell density. For fungi exhibiting yeast-mycelium
dimorphism, this phenomenon has been termed the inoculum
size effect (19). Under otherwise identical conditions, budding
yeasts are produced following inoculation at $106 cells/ml,
whereas germ tubes and mycelia are produced with inocula of
,106 cells/ml. We believe the inoculum size effect is a general
phenomenon for all dimorphic fungi. This effect has been
especially well documented for C. albicans. Cell density is
listed by Odds (26) as 1 of 11 general factors favoring the
filamentous form.
In this study we isolate and characterize the extracellular
quorum-sensing molecule (QSM) which is responsible for the
inoculum size effect in C. albicans. Quorum sensing is a well-
known phenomenon in prokaryotes, but it has as yet only been
hinted at in eukaryotes (18). Furthermore, since quorum sens-
ing uses extracellular signal molecules, it is poised to mediate
interactions of the producing fungus with its chemical and
physical environment as well as with other bacteria and fungi.
This study is the first to identify an extracellular molecule
(farnesol) which mediates a eukaryotic quorum-sensing sys-
tem.
MATERIALS AND METHODS
Organisms. C. albicans strains A-72 and SG10261 were obtained from Patrick
Sullivan, University of Otago, Dunedin, while strain MEN was from Richard
Cannon, University of Otago. Strain SG5314 was from Burk Braun, University of
California at San Francisco, and strains LGH 1095 and SG3314 were from Kevin
Hazen, Virginia Polytechnic Institute and State University. Homoserine lactone
(HSL) indicator strains were obtained from Sue Katz, Arizona College of Os-
teopathic Medicine, Glendale. (i) Chromobacterium violaceum CV026 was main-
tained on Luria-Bertani (LB) agar plus kanamycin (25 mg/ml). It detects four to
eight carbon N-acyl HSLs. (ii) Agrobacterium tumefaciens A136 (originally from
Clay Fuqua) was maintained on LB agar plus tetracycline (4.5 mg/ml) and
spectinomycin (50 mg/ml). It detects most C4 to C12 HSLs, regardless of whether
their side chains are 3-oxo, 3-hydroxy, or 3-unsubstituted (5, 29). (iii) Escherichia
coli strains MG4/pKDT17, DH5a/pECP 615, and DH5a/pQF300I were all main-
tained on LB agar plus ampicillin (100 mg/ml). They detect C10 to C14 3-oxo and
3-unsubstituted HSLs, PAI-2, and the Vibrio fischeri autoinducer 3-oxo C6 HSL,
respectively. QSM from C. albicans was concentrated by extraction into ethyl
acetate (6) and then tested for its reactivity toward five bacteria which had been
designed as indicator strains for the presence of various HSLs. C. violaceum
CV026 produces a purple pigment in response to the appropriate HSL, while the
other strains produce b-galactosidase. The CV026 assay was done on LB agar,
the three E. coli assays were done on LB agar with ampicillin (100 mg/ml) and
5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal; 40 mg/ml), and the
A136 assay was done on the minimal, defined AT-glucose agar (33) with X-Gal
(40 mg/ml).
Growth media and chemicals. GPP is the defined glucose-phosphate-proline
growth-medium described by Kulkarni and Nickerson (19). The modified glu-
cose-salts-biotin (GSB) growth medium contained (per liter of distilled water):
1 g of (NH4)2SO4, 2 g of KH2PO4, 50 mg of MgSO4 z 7H2O, 50 mg of CaCl2 z
2H2O, and 1 g of peptone. After autoclaving, 30 ml of a 50% (wt/vol) glucose
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stock and 0.4 ml of the GPP/GPR vitamin stock (19) were added aseptically. The
final pH was ca. 5.6. The modified GSB was used for preparing C. albicans cell
stocks. Cells were harvested after 30 h of growth, washed twice in 50 mM
K2HPO4 buffer (pH 6.5), and stored at 4°C in the same buffer at a cell density of
ca. 2 3 109 cells/ml. Supernatants containing QSM activity were prepared fol-
lowing 24 h of growth in GPP at 28°C, starting with an initial cell density of 107
cells/ml. For QSM preparation, GPP was always prepared with Kandiyohi dis-
tilled water (Kandiyohi Bottled Water Co., Willmar, Minn.). This precaution was
taken because several types of distilled water, including the building distilled
water for the Beadle Center at the University of Nebraska at Lincoln, permitted
ample growth of C. albicans, but the resulting cell-free supernatants did not
contain QSM activity. Currently, five of eight distilled waters locally available in
Lincoln and central Minnesota permit QSM accumulation. For the experiments
to determine the influence of carbon source on QSM production, the glucose in
GPP was replaced successively by lactose, sucrose, galactose, fructose, starch,
and glycerol. For the experiments to determine the influence of nitrogen source
on QSM production, the proline in GPP was replaced successively by L-serine,
L-arginine, L-alanine, L-histidine, L-threonine, L-methionine, and L-phenylala-
nine. The pH values for all of the resulting spent media were very similar (pH 6.1
to 6.4). The sample of mixed isomer farnesol was purchased from Acros Organics
(Pittsburgh, Pa.) while (E,E)-farnesol and farnesyl pyrophosphate were pur-
chased from Sigma (St. Louis, Mo.). (E,E)-Farnesol is also called trans-trans
farnesol.
QSM bioassay. Two complementary bioassays were used, both assessing the
percent germ tube formation (GTF) at 37°C but differing in whether or not the
cells are provided with a complete growth medium during the bioassay. The first,
an N-acetylglucosamine (GlcNAc)-triggered differentiation assay, included 0.56
ml of 0.1 M imidazole buffer (pH 6.5), 0.15 ml of 0.1 M MgSO4, 0.13 ml of 0.1
M GlcNAc, and 4.16 ml of either Kandiyohi distilled water or filter-sterilized
supernatant.
Bioassays of commercial chemicals were conducted by the addition of the
chemical, as a solution in 100% methanol, to the bioassay media; the final
concentration of methanol was never greater than 1%. The second, a mycelial
growth assay, included 0.5 ml of 0.5 M potassium phosphate buffer (pH 6.5), 0.5
ml of 20% glucose with 30 mM MgSO4, 0.17 ml of 0.3 M L-proline, 0.13 ml of 0.1
M GlcNAc, and 3.7 ml of either Kandiyohi distilled water or filter-sterilized
supernatant. In both cases, the assays were conducted in 25-ml Erlenmeyer flasks
using C. albicans inoculum which had been stored at 4°C in 50 mM potassium
phosphate buffer (pH 6.5). The cells were added in ;25-ml aliquots to pre-
warmed (37°C) assay medium to give a final cell density of 107 cells/ml. The flasks
were shaken on a New Brunswick Scientific G2 shaker at 37°C and 225 rpm for
4 h and examined for percent GTF by phase-contrast microscopy. At time zero,
the inoculated cells are .98% undifferentiated with 0% germ tubes and 0 to 2%
budding yeasts.
Purification of QSM. Five liters GPP was inoculated to a final concentration
of 107 cells/ml and incubated at 30°C for 24 h on a New Brunswick Scientific G52
shaker at 125 rpm. After 24 h the cultures were centrifuged at 15,300 3 g for 20
min. The supernatant was decanted and filter sterilized by vacuum filtration
through Whatman (Maidstone, United Kingdom) 0.45-mm (pore-size) cellulose
nitrate filters. The cell-free supernatant was either designated as spent medium
for use in a QSM assay or extracted with a one-fifth volume of ethyl acetate. The
ethyl acetate was removed under reduced pressure on a rotary evaporator. The
residue was suspended in a small volume of 1:4 ethyl acetate-hexane and the
soluble portion was subjected to silica flash chromatography with 1:4 ethyl
acetate-hexane as the eluant. Individual fractions (1 ml) were examined by
thin-layer chromatography (TLC).
TLC. TLC was conducted on silica gel G plates (Al or glass backed) containing
a fluorescent indicator (Alltech, Deerfield, Ill.). Reagents used for staining in-
cluded 1% aqueous KMnO4, an indicator for alkenes, and a mixture of p-
anisaldehyde and sulfuric acid in 1:1 methanol-water, which chars to reveal a
variety of organic functional groups. The mobile phase used was 1:4 ethyl ace-
tate-hexane.
HPLC. High-performance liquid chromatography (HPLC) analysis employed
a Waters (Milford, Mass.) pump model 510 and a Waters Tunable Absorbance
Detector model 486. Data were analyzed by using Millennium 2010 Chromatog-
raphy Manager software version 2.00 from Waters. A 5-mm C18 reversed-phase
column (4.6 by 250 mm) was used with the following parameters: 210-nm,
1-ml/min flow rate, and 4:1 methanol-H2O eluant.
FIG. 1. Two bioassays for QSM activity. Symbols: ■ and solid line, GlcNAc-triggered differentiation assay; Œ and dotted line, mycelial growth
assay. The indicated lines are linear regression lines with R2 values of 0.953 and 0.964, respectively. Values represent the average of five or more
experiments conducted over the past 4 years.
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GC-MS. Active fractions were resuspended in 100% methanol and analyzed by
a Hewlett-Packard 5972 Series II gas chromatography-mass spectroscopy (GC-
MS) with a 30-m DB-5 column in both the chemical ionization (methane) and
electron ionization (EI) modes. GC used a 1.5-ml sample, injector, and detector
temperatures of 250 and 280°C, respectively, and a temperature program of
100°C for 3 min and then 20°C/min until 280°C. MS used a 3-min solvent delay
and a scan rate of 1.5 scans/s.
Trimethylsilyl derivatization. Derivatization of the hydroxyl groups of com-
mercial farnesol and QSM was accomplished by the addition of N,O-bis(trim-
ethyl)trifluoroacetamide (BSTFA; Alltech). The samples were suspended in 500
ml of ethyl acetate, from which 150 ml was removed for analysis as “prior to
derivatization.” To the remaining 350 ml, 100 ml of BSTFA was added. The
samples were heated for 15 min at 70°C in a water bath and, after cooling, were
submitted directly for GC-MS.
RESULTS
QSM from C. albicans. Including spent media from C. albi-
cans as part of the fresh growth media caused a gradual shift in
the morphology of C. albicans. At 37°C, with no added culture
supernatant, the cells were ca. 90% mycelia. Incorporation of
spent growth medium progressively decreased the percent my-
celia to only 5 to 10% (Fig. 1). This decrease in the percent
mycelia occurred for both a complete growth medium and a
GlcNAc-induced differentiation assay for GTF. In both cases,
QSM did not just prevent GTF but also caused a morpholog-
ical shift to actively budding yeast cells.
Both the growth assay and the differentiation assay (Fig. 1)
used cell densities of 107 cells/ml with cells that had been
washed three times in 50 mM potassium phosphate buffer (pH
6.5). We washed the cells to remove residual QSM activity that
had accumulated during their growth in GSB medium. Two
washes were sufficient for maximum GTF during the assay
even though the first four washes still contained measurable
QSM activity (data not shown). For the cell growth bioassay
(Fig. 1), varying the initial cell density from 5 3 104 to 5 3
107/ml did not influence the results; QSM-containing spent
media shifted the percent mycelia from ca. 80 to 11% (data not
shown). For all subsequent assays we chose a cell density of
107/ml so as to avoid the reduced GTF evident at cell densities
of .5 3 107/ml, presumably due to QSM produced during the
4-h bioassay.
Generality within C. albicans. QSM activity was not specific
for strain A72; it was general for all strains of C. albicans
(Table 1). Supernatant from strain A72 caused a mycelium-
to-yeast conversion in cells from strains MEN, SG5314,
LGH1095, SG3314, and 10261 (Table 1). Similarly, superna-
tants from strains MEN, SG5314, LGH1095, SG3314, and
10261 caused a mycelium-to-yeast conversion in A72 cells (Ta-
ble 1). Thus, all six strains of C. albicans produce QSM activity,
and the QSMs for the six strains are either identical or very
similar to one another.
An exceptionally wide variety of conditions have been re-
ported to favor filamentation in C. albicans (26). Of these, the
most widely used methods for inducing germ tubes are serum
(15), buffered GlcNAc (30, 31), and L-proline (8). However,
QSM activity is not specific for a given method for germ tube
induction (Table 2). QSM acts to suppress germ tube induction
by GlcNAc, by serum, by L-proline, or by GlcNAc and proline
in combination (Fig. 1 and Table 2).
Production of QSM by C. albicans. QSM was produced by C.
albicans cells growing at all temperatures tested from 23 to
43°C (Table 3). From 23 to 37°C, there was a rough correlation
between cell number (in CFU/milliliters) and levels of QSM
produced, as indicated by the lower percent mycelia when
TABLE 2. Comparison of QSM effectiveness using different
methods of inducing GTF
Germ tube inducera
Morphology results
(mean % 6 SD)b for expts:
Without used
supernatant
With used
supernatant
10 mM proline 82 6 3 (Y) 100 6 0 (Y)
18 6 3 (M) 0 6 0 (M)
2.5 mM GlcNAc 26 6 4 (Y) 81 6 4 (Y)
74 6 5 (M) 19 6 4 (M)
10 mM proline 1 2.5
mM GlcNAc
15 6 1 (Y) 75 6 3 (Y)
84 6 1 (M) 25 6 4 (M)
2% fetal bovine serum 34 6 4 (Y) 97 6 2 (Y)
66 6 4 (M) 3 6 2 (M)
5% fetal bovine serum 7 6 1 (Y) 80 6 6 (Y)
92 6 1 (M) 21 6 5 (M)
10% fetal bovine serum 2 6 0 (Y) 65 6 4 (Y)
98 6 0 (M) 33 6 4 (M)
10% pig serumc 7 6 2 (Y) 32 6 2 (Y)
93 6 2 (M) 68 6 2 (M)
a Germ tube inducers present in 50 mM potassium phosphate (pH 6.5).
b “Y” and “M” are as defined in Table 1, footnote a. Supernatant was from
A-72 cells grown in GPP at 30°C for 24 h at 125 rpm at an inoculum of 107 cells
per ml. “Without used supernatant” samples received an equal amount of water
or 50 mM potassium phosphate (pH 6.5) instead of supernatant.
c The serum was nonpregnant pig serum.
TABLE 1. QSM cross-reactivity of A72 with five other
strains of C. albicans
Cell type
Morphology results (mean % 6 SD)a with:
37°C control Supernatant from A-72b A-72 cellsc
A-72 16 6 1 (Y) 71 6 4 (Y) 73 6 4 (Y)
83 6 1 (M) 26 6 4 (M) 24 6 3 (M)
MEN 49 6 6 (Y) 99 6 1 (Y) 61 6 3 (Y)
47 6 7 (M) 1 6 1 (M) 37 6 2 (M)
SG 5314 8 6 1 (Y) 44 6 6 (Y) 61 6 3 (Y)
92 6 1 (M) 53 6 2 (M) 39 6 3 (M)
LGH 1095 19 6 2 (Y) 88 6 3 (Y) 73 6 1 (Y)
78 6 3 (M) 10 6 2 (M) 27 6 1 (M)
SG 3314 20 6 9 (Y) 45 6 9 (Y) 74 6 4 (Y)
80 6 9 (M) 50 6 10 (M) 21 6 5 (M)
SG 10261 25 6 7 (Y) 57 6 12 (Y) 44 6 9 (Y)
72 6 8 (M) 34 6 15 (M) 55 6 10 (M)
a Morphology for the indicated strain in the growth-based bioassay in Fig. 1.
For the control, no QSM or spent media were added. Y, percent budding yeasts;
M, percent germ tubes for which the length of the germ tube was greater than the
diameter of the cell. For all tables, the “Y” and “M” values were obtained as
separate measurements so the values may not total 100%.
b Same experiment as in column 2 but with spent media from strain A-72.
c Morphology of A72 incorporating spent media from the indicated strain of
C. albicans.
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those supernatants were tested in a germ tube bioassay (Table
3). However, on a per-cell basis, significantly more QSM was
produced by cells grown at 40°C than at any other temperature
(Table 3).
C. albicans cells synthesized QSM continuously during
growth, and QSM activity persisted in the broth for at least 2
to 3 days after the onset of stationary phase (Fig. 2). QSM
production roughly paralleled cell growth (Fig. 2), and the
accumulation of QSM did not alter the growth rate of the
producing culture until the normal onset of stationary phase.
The levels of QSM produced were not dependent on the
type of growth medium or the specific carbon or nitrogen
source provided. Equivalent per-cell QSM production was ob-
served for cells grown (24 h at 25°C) in GPP, GSB (30),
modified GSB, Sabouraud-dextose, yeast extract-peptone-dex-
trose (1), yeast nitrogen base with either glucose or GlcNAc, or
Lee’s medium (20) (data not shown). Also, with GPP the
identity of the carbon source and the nitrogen source did not
seem to be important. Equivalent levels of QSM were pro-
duced with all seven carbon sources tested, including both
fermentable and nonfermentable (glycerol) carbon sources,
and all eight amino acid nitrogen sources (data not shown).
The small variations in QSM detected correlated well with the
cell titers obtained with the respective amino acids (data not
shown).
Preliminary evidence on the chemical identity of QSM. For
C. albicans, QSM activity could be extracted into ethyl acetate
and then resuspended in either hexane or 90% methanol (6,
21). Following an activity-directed purification, activity was
associated with a fraction containing a molecular mass of 222
(6, 21). Cho et al. (6) eliminated the possibilities that QSM was
methyl jasmonate or a lactone of jasmonic acid or homojas-
monic acid. Active fractions of QSM are stained by dilute
aqueous KMnO4 on silica TLC, indicating the presence of
carbon-carbon multiple bonds; absorb UV light at 210 to 220
nm but not at wavelengths of $240 nm; contain a free hy-
droxyl, as shown by altered mobility on TLC plates following
trimethylsilylation; do not contain a free carboxylic acid, as
shown by unaltered TLC mobility following reaction with dia-
zomethane; and do not contain an ester linkage, as shown by
the retention of activity after treatment with porcine liver es-
terase, hydrogen peroxide, basic methanol, or extremes in pH
(e.g., pH 7 to 2 to 7 or pH 7 to 12 to 7). Additionally, C.
albicans QSM is insensitive to trypsin, pronase, thermolysin,
and proteinase K (100 mg/ml for 2 h). Thus, QSM is unlikely to
be a conventional peptide. This distinction is important be-
cause of recent evidence that the “asexual” C. albicans can, in
FIG. 2. QSM production versus time. Supernatant samples were removed at the indicated times and used in the mycelial growth assay. Thus,
a higher percent yeast indicates more QSM activity. Values are the average of triplicate experiments. Symbols: F, initial cell density of 107/ml; ■,
initial cell density of 105/ml. pH and CFU/milliliter values were also determined at each time point. The two cultures shifted from exponential to
stationary phase at ca. 12 and 48 h, respectively, at a cell density of 2.8 3 108/ml in both cases.
TABLE 3. Effect of growth temperature on QSM production
Growth temp
(°C)a
Cell density at 24 h
(CFU/ml)
Morphology results
(mean % 6 SD)b
obtained with used
supernatant
23 (2.4 6 0.2) 3 108 55 6 6 (Y)
44 6 5 (M)
27 (3.2 6 0.4) 3 108 71 6 3 (Y)
28 6 2 (M)
30 (3.7 6 0.2) 3 108 75 6 2 (Y)
23 6 2 (M)
33 (2.8 6 0.1) 3 108 84 6 3 (Y)
16 6 3 (M)
37 (3.6 6 0.1) 3 108 99 6 2 (Y)
1 6 2 (M)
40 (4.0 6 0.1) 3 107 94 6 2 (Y)
6 6 2 (M)
43 (4.0 6 0.8) 3 107 72 6 3 (Y)
27 6 3 (M)
a Cultures were inoculated to a cell density of 107 per ml in GPP and incubated
at the indicated temperature for 24 h on a New Brunswick Scientific G52 shaker
at 125 rpm.
b Growth morphology-based bioassay was done as described in Fig. 1 (all at
37°C) using QSM from spent media produced by growth on GPP at the indicated
temperatures. “Y” and “M” are as defined in Table 1, footnote a.
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fact, undergo mating (14, 23). It is also unlikely to be an HSL.
The C. albicans QSM was tested versus three bacterial strains
which act as reporter strains for a wide range of bacterial HSLs
(5, 29). However, in no case did the C. albicans extracts elicit
the indicated color development, while in each case the appro-
priate bacterial positive controls did elicit that response (data
not shown).
Heat stability of QSM. The QSM activity of C. albicans was
unchanged by heating at 100°C for 30 min or by autoclaving
(data not shown), and activity was retained for at least 3 years
at 4°C. It did not matter whether the supernatants were stored
in glass or polypropylene vessels. Additionally, QSM activity
remained unchanged following 12 freeze-thaw cycles (data not
shown).
GC-MS. Fractions enriched in the C. albicans QSM showed
peaks at 9.8, 9.9, and 10.0 min when examined by GC-MS.
These three peaks were analyzed with the MS system in both
the chemical ionization (CI) mode (Fig. 3), which emphasizes
the parent compound’s molecular weight, and the electron
induced (EI) ionization mode (Fig. 4), which emphasizes frag-
FIG. 3. GC-MS analysis of QSMs from C. albicans using the CI mode for MS. Samples were run in August 1997. (A) GC showing peak A at
9.88 min, peak B at 9.93 min, and peak C at 10.06 min. (B) MS fragmentation pattern of peak A. (C) MS fragmentation pattern of peak B. (D)
MS fragmentation pattern of peak C. The MS patterns only show ions of $100 m/z.
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mentation data. The three peaks contained the same parent
ion (M1H) at m/z 223 in CI mode (Fig. 3) and exhibited the
same fragmentation patterns in EI mode (Fig. 4). Presumably,
the three peaks represent isomers of one another. Analysis of
the results using a library search program (35) suggested
3,7,11-trimethyl-2,6,10-dodecatrien-1-ol (molecular weight 5
222.37), better known as the 15-carbon sesquiterpene farnesol.
Farnesol can exist as both E and Z geometric isomers at both
the 2/3 and 6/7 double bonds, for a total of four possible
isomers. When a commercial sample of farnesol, containing a
mixture of isomers, was analyzed by GC-MS, three peaks were
seen at 9.7, 9.85, and 10.0 min (data not shown) with the
relative peak areas of 6:57:37. The commercial sample of
(E,E)-farnesol showed only a single peak at 10.0 to 10.1 min
(data not shown). In both the CI and the EI modes, the frag-
mentation patterns of QSM were identical to those of com-
mercial farnesol. At no stage of the QSM analysis did we
observe GC-MS peaks containing molecules of 154.2 or 290.5
molecular weight, as would be expected for geraniol (C10) and
geranylgeraniol (C20), respectively.
FIG. 3—Continued.
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Confirmation of farnesol by trimethylsilylation. Trimethyl-
silylation is a common method of derivatizing aliphatic alco-
hols for analysis by GC-MS. In CI mode, the peaks for deri-
vatized mixed isomer farnesol shifted from 9.7, 9.85, and 10.0
min to 10.15, 10.22, and 10.35 min, respectively, while the
parent ions shifted from 223 to 293 Da (data not shown).
Trimethylsilyl derivatization of the C. albicans QSM also
shifted the dominant peak from 10.0 to 10.35 min, and the new
parent ion and fragmentation pattern were identical to those of
the (E,E)-farnesol standard (data not shown). The addition of
a single trimethylsilyl group is consistent with farnesol but
inconsistent with two related C15 molecules: the hormone si-
renin produced by the water mold Allomyces (11) and the
farnesylated portion of the mating pheromones from Tremero-
gen A-10 and Tremerogen A-9291-I both of which have an extra
hydroxyl on the 12 position of their farnesol modification (4).
FIG. 4. GC-MS analysis of two QSM-containing column fractions (fractions 5 and 7) using the EI mode for MS. Samples were run in September
2000. (A) GC of fraction 5 showing peak A at 9.77 min, peak B at 9.84 min, and peak C at 9.98 min. (B) MS fragmentation pattern of peak A from
fraction 5. (C) MS fragmentation pattern of peak B from fraction 5. (D) GC of fraction 7 showing primarily peak C at 9.98 min. (E) MS
fragmentation pattern of peak C from fraction 7. The MS patterns show ions of $50 m/z. The strong band at m/z 69 is characteristic of a C5H9
isoprene unit.
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Farnesol bioassay data. Commercial preparations of mixed-
isomer farnesol (1-hydroxy-3,7,11-trimethyl-2,6,10-dodecatri-
ene), (E,E)-farnesol, and mixed-isomer nerolidol (3-hydroxy-
3,7,11-trimethyl-1,6,10-dodecatriene) were tested for their
ability to block GTF. All three showed strong QSM activity in
that they reduced GTF by 50% at concentrations of 30 to 35
mM for the farnesol preparations and of ca. 60 mM for the
nerolidol.
Two fractions (fractions 5 and 7) from a silica flash column
separation of an ethyl acetate extract of the C. albicans super-
nate were compared by GC-MS. The three isomers of farnesol
were separated by GC at 9.7, 9.85, and 10.0 min. For the
comparatively inactive fraction 5 (87% GTF by bioassay), the
three peaks were 65, 25, and 10% of the total peak area,
respectively, whereas for the highly active fraction 7 (only 19%
GTF by bioassay), the three peaks were 14, 6, and 80% of the
total peak area, respectively.
Confirmation of farnesol by TLC. The Rf values of commer-
cial mixed isomer and (E,E)-farnesol were compared with
those of the QSM-enriched fractions 5 and 7 from C. albicans
FIG. 4—Continued.
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supernatant. The mixed isomer farnesol ran as a broad band of
Rf 0.45 to 0.47, while the (E,E)-farnesol ran as a single band
with Rf 0.45, coeluting with the dominant band from the active
fraction 7 from C. albicans. TLC analysis of the active chro-
matographic fractions derived from C. albicans also was con-
ducted using p-anisaldehyde (data not shown). An advantage
of this reagent is the ability to produce dramatically different
colors depending upon the functionality present in the mole-
cule (7). The two commercial farnesol bands stained blue
green with p-anisaldehyde, as did the Rf 0.45 and 0.47 bands
from C. albicans supernatant. All of the other bands from C.
albicans stained pink or yellow with p-anisaldehyde (data not
shown). The apparent shift in QSM’s Rf value from 0.50 re-
ported previously (6) to 0.45 merely reflects a switch in the
TLC mobile phase from 25% ethyl acetate-hexane to 20%
ethyl acetate-hexane.
Confirmation of farnesol by HPLC. The commercial mixed
isomer and (E,E)-farnesol were compared with the QSM-en-
riched fraction 7 from C. albicans by C18-reversed phase high-
pressure liquid chromatography (HPLC) monitored at 210 nm
(Fig. 5). The mixed-isomer farnesol showed peaks at 11.2, 11.7,
and 12.4 min, which were present as the percent area in the
ratio 6:56:38. In a separate experiment the (E,E)-farnesol
showed a single peak at 12.4 min. This separation of the far-
nesol isomers duplicates the separation achieved by GC, and in
both cases the (E,E)-isomer traveled the furthest. Once again,
just as with the GC comparison, the position of the major peak
for QSM enriched fraction 7 coincided with the peak for (E,E)-
farnesol (Fig. 5).
Farnesol and growth. In assessing the specificity of farnesol’s
QSM activity, it is important to determine whether farnesol
slows down the overall growth rate for C. albicans. It did not.
At concentrations of up to 250 mM, farnesol did not alter the
growth rate for C. albicans at 30°C. Actively budding yeasts
were observed in both cases.
DISCUSSION
Our studies demonstrate that there is an inoculum size effect
in the dimorphic fungus C. albicans that is mediated by extra-
cellular farnesol. Farnesol acts as a QSM in that it prevents the
mycelial phase of growth, with a mycelium/yeast threshold at
ca. 106 cells/ml in liquid culture. Both QSM purified from C.
albicans and commercial farnesol shifted the morphology of C.
albicans from mycelia to actively budding yeasts and, at con-
centrations of up to 250 mM, farnesol did not inhibit the
FIG. 5. HPLC comparison of mixed-isomer farnesol versus active
fraction 7 from C. albicans supernatant. The separation used a C18
reversed phase column eluted with 80% methanol-water monitored at
210 nm. The mixed-isomer farnesol peaks at 11.2, 11.7, and 12.4 min
were present (percent area) in the ratio of 6:56:38. The solid line
represents 0.4 mM mixed-isomer farnesol.
FIG. 4—Continued.
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growth rate of C. albicans. We hypothesize that the inoculum
size effect is a common phenomenon in the biology of dimor-
phic fungi for which C. albicans is a useful model system.
We believe this report is the first structural identification of
a quorum-sensing system in fungi and the first identification of
farnesol production by C. albicans. Farnesol is not mentioned
in Odds’ (26) comprehensive review of Candida, two recent
reviews of the lipids of C. albicans (16, 27), or two standard
texts on fungal physiology (10, 12). Farnesol (QSM) is distinct
from the morphogenic autoregulatory substance (MARS) iso-
lated from C. albicans by Hazen and Cutler (13). Both QSM
and MARS are extracellular molecules produced by C. albi-
cans that act to suppress the yeast-to-mycelium transition.
However, MARS differs in that it has a UV maximum at 270
nm, has a nitrogen-containing ring system, reacts with ninhy-
drin to form a yellow color, has to be bioassayed within 2 days,
is inactivated by pH values of ,4.5 or .9.0, and has no aroma.
The physical properties of farnesol are appropriate for its
role as a QSM; it is lipophilic, with a water solubility of only 1.2
mM (17). In contrast, geranylgeraniol (C20) is not suitable as a
QSM because it is not soluble in water, while geraniol (C10) is
sufficiently soluble (7.6 mM) but is generally toxic to strains of
Candida (2). The properties of farnesol as a QSM are consis-
tent with those expected for a fungal quorum-sensing system.
(i) It is extracellular, is diffusible, and can be removed from
cells by washing. (ii) It is produced continually during growth
in amounts roughly proportional to cell mass. (iii) It is pro-
duced by all six strains of C. albicans tested. (iv) It blocks the
induction of germ tubes by three chemically distinct triggers:
L-proline, GlcNAc, and serum. (v) Its production is dependent
on cell growth and not on a particular carbon or nitrogen
source. (vi) It alters cell morphology but does not alter growth
rate. Thus, its mode of action is likely more specific than just a
general inhibition of cell metabolism. (vii) It is produced at all
growth temperatures and is itself very heat stable. Even though
QSM functions by inhibiting the shift from yeasts to mycelia, C.
albicans produces as much or more QSM at temperatures of
$37°C, where in vitro the cells are growing in the mycelial
mode. This continued production of QSM at temperatures of
$37°C. (i) explains why GTF assays at 37°C have to be con-
ducted at cell densities of #107/ml; (ii) means that QSM for-
mation should occur in the human body during candidiasis;
and (iii) precludes the simple, discontinuous model wherein
GTF and mycelial growth only occur at temperatures of $37°C
because QSM production does not occur at temperatures
above 35 to 36°C.
Farnesol has three carbon-carbon double bonds and exists in
four isomers. In this regard, we do not see any inconsistency
between the facts that C. albicans excretes primarily the (E,E)-
farnesol, while commercial (E,E)-farnesol and mixed-isomer
farnesol have equivalent activities and the closely related ses-
quiterpene nerolidol is also highly active. The fungus Hel-
minthosporium sativum has an enzymatic system for the cis-
trans isomerization of the 2,3 double bond of farnesol and
epoxy-farnesol using nerolidol as an intermediate (32). The
presence of a similar system in C. albicans could allow inter-
conversion of nerolidol and the two farnesols. Also, recogni-
tion that C. albican’s QSM is slightly volatile explains. (i) why
measurements of QSM’s heat stability had to be conducted in
sealed tubes; (ii) why there was a gradual decline in QSM
activity during stationary phase (Fig. 2), even though purified
QSM was stable for at least 3 years at 4°C; and (iii) the diffi-
culty we experienced in making quantitative comparisons be-
tween QSM activity in the initial supernatants and the amounts
of farnesol purified following extraction into ethyl acetate—a
high proportion of the farnesol was lost when the ethyl acetate
was reduced in volume by rotary evaporation.
The older literature offers ample precedent for the existence
of fungal QSMs. Odds (26) cited 13 references that an inocu-
lum size of #106/ml favored filamentous growth. A diffusible
filament-suppressing molecule was hypothesized based on the
distinctive morphology of C. albicans on agar plates following
parallel streaking (24) or multiple cross-streaking (25). For
instance, Nickerson and Chung (25) noted the “suppression of
filamentation in strain 582 (a wild-type dimorphic strain of C.
albicans) along the length of the streak facing strain 806 and
the appearance of filaments in 582 only at the free ends of
lateral streaks,” while with three parallel streaks filamentous
cells only arose from the outer borders of the two outer streaks
(24). Similarly, Shepherd and Sullivan (30) noted that some C.
albicans strains needed to be “activated or conditioned” for
GTF by a prolonged aeration under nongrowing conditions.
This conditioning, like the successive cell washings described
here, would serve to remove excess QSM from the C. albicans
cells.
Recognition that farnesol acts to suppress mycelial develop-
ment in C. albicans in a quorum-sensing manner suggests that
farnesol might be the first of a novel class of antifungal com-
pounds. C. albicans normally occurs as a yeast in the human
gastrointestinal tract but can form germ tubes in response to an
unknown chemical inducer(s). The germ tubes (mycelia) can
invade the intestinal wall to enter the blood stream. This mor-
phological transformation from yeast to mycelia is a crucial
step in the pathogenesis of C. albicans. Blocking this transition
could block the pathogenic nature of this opportunist. These
compounds would neither kill the fungi nor prevent their
growth. Instead, they would limit their growth to a single mor-
phological form and in so doing restrict pathogenesis. Nonfila-
mentous mutants of C. albicans are often avirulent (22). We
believe this type of single morphology therapy could be espe-
cially useful in immunocompromised patients because it would
not upset the natural resident flora. Additionally, because it
does not kill the fungus, selection for farnesol-tolerant mutants
should not be as intense.
Finally, we suggest that the effects of excreted farnesol may
be different in vitro and in vivo. All of our results so far have
been in vitro; accumulated farnesol (10 to 50 mM) shifted the
morphology to budding yeasts. If this suppression of mycelial
development also occurs in vivo, the effect of exogenous far-
nesol should be protective because nonfilamentous mutants of
C. albicans are often avirulent (22). However, in vivo farnesol
excretion may instead act as a virulence factor. In patients, C.
albicans accumulates to very high cell densities and then some
of these cells penetrate the tissue. Growth to high cell densities
in the restricted microenvironments of the host mucosal foci
may produce enough farnesol so that the cells lining the mi-
croabscesses no longer constitute an effective barrier to fungal
penetration. Free farnesol is not normally present at detect-
able levels in human plasma (28). The lipophilic properties of
free farnesol would favor its membrane localization, and thus
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it could alter the membrane fluidity of the host cells. Alterna-
tively, according to Voziyan et al. (34), the farnesol could
reduce diacylglycerol production. Since diacylglycerol is an ac-
tivator for protein kinase C, farnesol could inhibit cell growth,
leading to apoptosis (34), and thus create an entry site for
invading C. albicans. Tests with farnesol and C. albicans in a
mouse model system (9) should resolve these competing hy-
potheses.
ACKNOWLEDGEMENTS
We thank Bill Gerwick, Department of Pharmacy, Oregon State
University, for hospitality during K.W.N’s recent sabbatical, as well as
for the use of GC-MS equipment with a computerized database, Gloria
Zeller (Oregon State University) for technical assistance with the bac-
terial HSL indicator strains, Antonio Romano for pointing out how the
early work of W. J. Nickerson indicated a diffusible filament-suppress-
ing molecule, and Sondra Atkins for assistance with manuscript prep-
aration.
REFERENCES
1. Atlas, R. M. 1993. Handbook of microbiological media. CRC Press, Boca
Raton, Fla.
2. Bard, M., M. R. Albrecht, N. Gupta, C. J. Guynn, and W. Stilwell. 1988.
Geraniol interferes with membrane functions in strains of Candida and
Saccharomyces. Lipids 23:534–538.
3. Brown, A. J. P., and N. A. R. Gow. 1999. Regulatory networks controlling
Candida albicans morphogenesis. Trends Microbiol. 7:333–338.
4. Caldwell, G. A., F. Naider, and J. M. Becker. 1995. Fungal lipopeptide
mating pheromones: a model system for the study of protein prenylation.
Microbiol. Rev. 59:406–422.
5. Cha, C., P. Gao, Y.-C. Chen, P. D. Shaw, and S. K. Farrand. 1998. Produc-
tion of acyl-homoserine lactone quorum sensing signals by gram-negative
plant-associated bacteria. Mol. Plant-Microbe Interact. 11:1119–1129.
6. Cho, S. C., P. H. Dussault, A. D. Lisec, E. C. Jensen, and K. W. Nickerson.
1999. Metathesis-based synthesis of jasmonate and homojasmonate lactones,
candidates for extracellular quorum sensing molecules in Candida albicans.
J. Chem. Soc. Perkin Trans. 1:193–196.
7. Coscia, C. J. 1984. Handbook of chromatography: terpenoids. CRC Press,
Boca Raton, Fla.
8. Dabrowa, N., S. S. S. Taxer, and D. H. Howard. 1976. Germination of
Candida albicans induced by proline. Infect. Immun. 13:830–835.
9. de Repentigny, L., M. Phaneuf, and L.-G. Mathieu. 1992. Gastrointestinal
colonization and systemic dissemination by Candida albicans and Candida
tropicalis in intact immunocompromised mice. Infect. Immun. 60:4907–4914.
10. Garraway, M. O., and R. C. Evans. 1984. Fungal nutrition and physiology,
John Wiley & Sons, New York, N. Y.
11. Gooday, G. W., and D. J. Adams. 1993. Sex hormones and fungi. Adv.
Microb. Physiol. 34:69–145.
12. Griffin, D. H. 1994. Fungal physiology, 2nd ed. Wiley-Liss, New York, N. Y.
13. Hazen, K. C., and J. E. Cutler. 1983. Isolation and purification of morpho-
genic autoregulatory substance produced by Candida albicans. J. Biochem.
94:777–783.
14. Hull, C. M., R. M. Raisner, and A. D. Johnson. 2000. Evidence for mating of
the “asexual” yeast Candida albicans in a mammalian host. Science 289:307–
310.
15. Joshi, K. R., D. A. Bremner, J. B. Gavin, P. B. Herdson, and D. N. Parr. 1973.
The formation of germ tubes by Candida albicans in sheep serum and
trypticase soya broth. Am. J. Clin. Pathol. 60:839–842.
16. Kitajima, Y., and Y. Nozawa. 1996. Lipids and dimorphism of Candida
albicans and Sporothrix schenckii, p. 219–233. In R. Prasad and M. A. Gha-
nnoum (ed.), Lipids of pathogenic fungi. CRC Press, Boca Raton, Fla.
17. Knobloch, K., A. Pauli, B. Iberl, N. Weis, and H. Weigand. 1988. Mode of
action of essential oil components on whole cells of bacteria and fungi in
plate tests, p. 287–299. In P. Schreier (ed.), Bioflavour’87. Walter de Gruyter,
Berlin, Germany.
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